| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |